Aclarion (ACONW) Gains from Sales and Divestitures (2022 - 2024)

Aclarion (ACONW) reported Gains from Sales and Divestitures of $1.0 for Q4 2024, down 50.0% on a YoY basis from $2.0 in Q1 2024, and down 99.98% quarter-over-quarter from $5469.0 in Q3 2024.

Aclarion (ACONW) Gains from Sales and Divestitures (2022 - 2024) Analysis & Trends

Aclarion has reported Gains from Sales and Divestitures for 3 years, with the latest figure at $1.0 in Q4 2024.

  • For the quarter ending Q4 2024, Gains from Sales and Divestitures fell 50.0% year-over-year to $1.0; the trailing twelve-month figure through Dec 2024 stood at $1.0 (down 50.0% YoY), and the FY2024 full-year result was $1.0, down 50.0% from the prior year.
  • Gains from Sales and Divestitures for Q4 2024 stood at $1.0, down from $5469.0 in the prior quarter.
  • The five-year high for Gains from Sales and Divestitures was $327230.0 in Q3 2023, with the low at $1.0 in Q4 2024.
  • Historically, Gains from Sales and Divestitures has averaged $70542.3 across 3 years, with a median of $3953.0 in 2024.
  • Annual changes were most pronounced in 2023 — Gains from Sales and Divestitures plunged 99.95% — and 2024, when it sank 50.0%.
  • Aclarion's Gains from Sales and Divestitures stood at $3864.0 in 2022, then sank by 99.95% to $2.0 in 2023, then slumped by 50.0% to $1.0 in 2024.
  • The last three Gains from Sales and Divestitures figures came in at $1.0 (Q4 2024), $5469.0 (Q3 2024), and $3953.0 (Q2 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Veeva Systems 26.11 Bn 18.79 Bn 662.02 Mn
2 BrightSpring Health Services 12.95 Bn 12.07 Bn 482.22 Mn
3 Healthequity 7.46 Bn 7.19 Bn 256.31 Mn
4 Hinge Health 5.15 Bn 4.83 Bn 154.23 Mn
5 Doximity 3.75 Bn 3.00 Bn 125.97 Mn
6 10x Genomics 3.69 Bn 3.15 Bn 106.18 Mn
7 Waystar Holding 3.61 Bn 3.45 Bn 268.04 Mn
8 Privia Health 2.90 Bn 2.54 Bn 595.71 Mn
9 Omnicell 1.72 Bn 1.54 Bn 140.36 Mn
10 Aclarion - - 3,750.00

Historic Data

Download Data
DateValue
Dec 31, 2024 1.00
Dec 31, 2024 1.00
Sep 30, 2024 5,469.00
Sep 30, 2024 5,469.00
Jun 30, 2024 3,953.00
Jun 30, 2024 3,953.00
Mar 31, 2024 2,554.00
Mar 31, 2024 2,554.00
Dec 31, 2023 2.00
Dec 31, 2023 2.00
Sep 30, 2023 327,230.00
Sep 30, 2023 327,230.00
Jun 30, 2023 206,302.00
Jun 30, 2023 206,302.00
Mar 31, 2023 85,506.00
Mar 31, 2023 85,506.00
Dec 31, 2022 3,864.00
Dec 31, 2022 3,864.00